InspireMD to Present at the Cowen and Company 35th Annual Healthcare Conference

Presentation to be Webcast on March 3, 2015 at 10:40 a.m. ET

BOSTON, MA – February 26, 2015 — InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection systems (“EPS”), today announced that its Chief Executive Officer, Alan Milinazzo, will present at the Cowen and Company 35th Annual Healthcare Conference on Tuesday, March 3, 2015 at 10:40 a.m. ET. The conference will be held in Boston, MA.

A live webcast will be available for those participants who are unable to attend, which can be found at: http://wsw.com/webcast/cowen22/nspr. The webcast will be available for 90 days following the presentation.

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MGuard™ with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

InspireMD intends to pursue applications of this MicroNet™ technology in coronary, carotid (CGuard™) and peripheral artery procedures. InspireMD’s common stock is quoted on the NYSE MKT under the ticker symbol NSPR.

Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
Phone: 1-888-776-6804
Email: craigs@inspiremd.com